课题基金 / 基金详情

Towards an HIV cure for all: increasing female representation in HIV latency research

Towards an HIV cure for all: increasing female representation in HIV latency research
实现全民艾滋病毒治愈:增加艾滋病毒潜伏期研究中的女性代表性
批准号:
416770
负责人:
Shahid Aniqa
金额:
$7.65万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-11-01 至 2022-11-01

项目摘要

项目成果

Shahid Aniqa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite the success of antiretroviral therapy to treat HIV infection, these medications are not curative and need to be taken for life. This is because HIV integrates its genetic material into the genome of the infected human immune cells, and can persist
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV genetic diversity and compartmentalization in lung and blood
Phylogenetic and phylodynamic analysis of Hepatitis C epidemic in Pakistan
HLA-B*13-associated polymorphisms reduce HIV-1 Nef's capacity to downregulate HLA class I from the cell surface
Impact of HLA-B*13 associated polymorphisms on HIV-1 Replication Capacity
国内基金
海外基金
Cellular & Molecular Immunology
  • 批准号:
    30824806
  • 项目类别:
    专项基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2008
  • 负责人:
    魏海明
  • 依托单位: